APA (7th ed.) Citation

SS, C., JG, J., SC, L., YH, Y., TW, C., C, L., . . . HM, C. (2026). TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity. Haematologica, 111(4), 1474. https://doi.org/10.3324/haematol.2025.288692

Chicago Style (17th ed.) Citation

SS, Cheng, Jiang JG, Lin SC, Yu YH, Chang TW, Lim C, Yu YB, and Chu HM. "TE-1146, a Novel Anti-CD38-antibody-lenalidomide Conjugate, Demonstrates Potent Ex Vivo Anti-myeloma Activity." Haematologica 111, no. 4 (2026): 1474. https://doi.org/10.3324/haematol.2025.288692.

MLA (9th ed.) Citation

SS, Cheng, et al. "TE-1146, a Novel Anti-CD38-antibody-lenalidomide Conjugate, Demonstrates Potent Ex Vivo Anti-myeloma Activity." Haematologica, vol. 111, no. 4, 2026, p. 1474, https://doi.org/10.3324/haematol.2025.288692.